Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:e35
Published online before print April 19, 2007, doi: 10.1161/STROKEAHA.107.482885
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/6/e35    most recent
STROKEAHA.107.482885v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly-Hayes, M.
Right arrow Articles by Wolf, P. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kelly-Hayes, M.
Right arrow Articles by Wolf, P. A.

(Stroke. 2007;38:e35.)
© 2007 American Heart Association, Inc.


Letters to the Editor

Response to Letter by Vale

Margaret Kelly-Hayes, Ed.D, RN Philip A. Wolf, MD

Department of Neurology, Boston University School of Medicine, Boston, Mass

Response:

We thank Dr Vale for his comments on our study. He raises an interesting question as to whether deregulated stress response could be an underlying mechanism for the association between depressive symptoms and risk of stroke. As we stated in our article, the biological pathways by which depressive symptoms are associated with stroke risk remain unclear. Do psychological factors act to augment stroke risk or are they the result of a subclinical cerebrovascular process evident on brain MRI1? Dr Vale has suggested a plausible mechanism not considered in our discussion: namely, that there is a subgroup of depressed individuals who react to mental stress with intense immune activation thus making them more prone to atherosclerosis. He proposes that it may be worthwhile to measure salivary {alpha}-amylase, which has been shown to be elevated at times of psychological stress in healthy adults. However, increased levels of salivary {alpha}-amylase have not been demonstrated prospectively to be associated with increased incidence of stroke or other cardiovascular disease. We thank Dr Vale for bringing this novel hypothesis to our attention.

Acknowledgments

Disclosures

None.

References

1. Steffens DC, Krishnan RR, Crump C, Burke GL. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke. 2002; 33: 1636–1644.[Abstract/Free Full Text]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/6/e35    most recent
STROKEAHA.107.482885v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly-Hayes, M.
Right arrow Articles by Wolf, P. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kelly-Hayes, M.
Right arrow Articles by Wolf, P. A.